Parkman Healthcare Partners’s EDAP TMS S.A. FOCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$576K Hold
154,832
0.06% 87
2025
Q4
$509K Hold
154,832
0.05% 97
2025
Q3
$355K Hold
154,832
0.04% 90
2025
Q2
$255K Hold
154,832
0.03% 88
2025
Q1
$303K Hold
154,832
0.04% 90
2024
Q4
$342K Hold
154,832
0.05% 89
2024
Q3
$395K Buy
+154,832
New +$634K 0.05% 90
2021
Q3
Sell
-346,926
Closed -$2.46M 76
2021
Q2
$2.46M Sell
346,926
-226,448
-39% -$1.64M 0.54% 51
2021
Q1
$4.82M Buy
573,374
+443,485
+341% +$3.61M 1.12% 28
2020
Q4
$672K Buy
129,889
+4,889
+4% +$22K 0.17% 78
2020
Q3
$575K Buy
+125,000
New +$431K 0.15% 77

Other funds holding FOCL

Parkman Healthcare Partners's FOCL Position: Q1 2026 in Review

Parkman Healthcare Partners held its EDAP TMS S.A. (FOCL) position steady in Q1 2026 at 154,832 shares worth $576K. The position accounts for 0.06% of the portfolio, ranked #87.

Parkman Healthcare Partners first reported a position in FOCL in Q3 2020 and has held it in 11 quarters since. The position peaked at $4.82M in Q1 2021. 36 funds tracked by Wall St. Rank hold FOCL as of Q1 2026.

  • Parkman Healthcare Partners held 154,832 shares of EDAP TMS S.A. worth $576K as of Q1 2026.
  • Parkman Healthcare Partners left its EDAP TMS S.A. share count unchanged in Q1 2026.
  • EDAP TMS S.A. made up 0.06% of Parkman Healthcare Partners's portfolio in Q1 2026, its #87 holding.
  • Parkman Healthcare Partners first reported a position in EDAP TMS S.A. in Q3 2020 and has held it in 11 quarters since.
  • Parkman Healthcare Partners's EDAP TMS S.A. position peaked at $4.82M in Q1 2021.
  • 36 funds tracked by Wall St. Rank held EDAP TMS S.A. as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.